Invention Grant
US07241733B2 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
有权
哺乳动物EPO模拟CH1缺失的模拟物，组合物，方法和用途
- Patent Title: Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
- Patent Title (中): 哺乳动物EPO模拟CH1缺失的模拟物，组合物，方法和用途
-
Application No.: US10609783Application Date: 2003-06-30
-
Publication No.: US07241733B2Publication Date: 2007-07-10
- Inventor: George A. Heavner , David M. Knight , John Ghrayeb , Bernard J. Scallon , Thomas C. Nesspor , Karen A. Kutoloski
- Applicant: George A. Heavner , David M. Knight , John Ghrayeb , Bernard J. Scallon , Thomas C. Nesspor , Karen A. Kutoloski
- Applicant Address: US PA Malvern
- Assignee: Centocor, Inc.
- Current Assignee: Centocor, Inc.
- Current Assignee Address: US PA Malvern
- Main IPC: C07K14/505
- IPC: C07K14/505
Abstract:
The present invention relates to at least one novel human EPO mimetic CH1 deleted mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one EPO mimetic CH1 deleted mimetibody or specified portion or variant, CH1 deleted mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Public/Granted literature
- US20050191301A1 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses Public/Granted day:2005-09-01
Information query
